The novel treatment of this peptide represents a significant advance in the care of the condition. Distinct from existing medications, tirzepatide targets dual pathways – glucagon-like peptide-1 (GLP-1) and the GIP https://tirzepatidepeptide088821.free-blogz.com/89637156/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment